Australia’s drugstore wholesaler, Sigma Healthcare, has announced it will expand into the UK, with the acquisition of a 75% stake in a number of stores from Greenlight Healthcare Limited.

Sigma Healthcare will license the Chemist Warehouse brand and lead the customer-facing retail model, including assortment strategy, store execution, inventory flow and marketing. In parallel, Greenlight will underpin the operating model, managing dispensary services and core back-end infrastructure.

Chemist Warehouse’s entry into new markets has historically been accompanied by significant price disruption. Its operating model of high-volume purchasing, lean store formats, and strong supplier negotiations has allowed it to undercut competitors.

Chemist Warehouse’s strengths

Chemist Warehouse is anchored in a clear value proposition, underpinned by consistent price leadership. With more than 550 stores in Australia, and a growing presence in New Zealand, Ireland, Dubai and China, the retailer has significant purchasing power, enabling it to pass meaningful savings on to shoppers.

In addition, its no-frills, highly functional store format keeps operating costs tightly controlled, while layouts are optimised to maximise product visibility and drive impulse purchasing.

Growth drivers and expansion

In its latest half-yearly results (H1 2026), Chemist Warehouse’s Australia-based sales were up 17.2%, with like-for-like sales up 15%. Growth also accelerated in its international markets, where network sales rose by 24.5%.

The retailer also revealed that demand for blockbuster weight-loss drugs is driving double-digit sales growth at its pharmacies. With cheaper pill versions of the weekly injection expected in the Australian market in 2026, growth is expected to accelerate.

Sigma Healthcare is driving growth through four pillars: maintaining leadership in its domestic market, driving profitable growth internationally, product differentiation through owned and exclusive products and delivering efficiencies and synergy programmes.

What’s next?

The partnership will initially focus on identifying suitable existing Greenlight pharmacy locations and, where viable, converting or relocating these into Chemist Warehouse formats. Phase one will centre on the rebranding and development of up to five pilot stores, providing a test-and-learn platform ahead of a potential broader rollout in phase two, subject to performance. The first site is set to launch on Hoxton Street in northeast London, marking the initial step in establishing a physical presence in the market.

What are the implications for the UK market?

Chemist Warehouse’s entry signals a new phase of value disruption in UK health & beauty. The retailer’s model, which is anchored in deep price leadership and high‑volume purchasing, has consistently reset category price expectations in each market it has entered. Its launch in Ireland has already demonstrated this effect, with sharp price gaps on branded beauty, vitamins and fragrance quickly drawing shopper attention and prompting competitive responses. A similar dynamic is likely in the UK, where inflation has heightened demand for low‑priced branded essentials.

For established players such as Boots, Superdrug, Savers and the grocers, Chemist Warehouse adds a competitor willing to run on lower margins to win scale. Its simple, functional store format is built for volume rather than experience. This is likely to increase pressure in categories where profits are already tight, especially OTC, vitamins, fragrance and everyday personal care.

The model also brings new expectations for suppliers. Chemist Warehouse typically seeks exclusive packs, sharper net pricing and fast‑moving promotional mechanics, creating both opportunities for volume growth and challenges around margin. Its partnership with Greenlight further signals the potential for hybrid pharmacy‑retail formats to gain traction, reshaping competitive dynamics across community pharmacy and mass health & beauty.

Looking for more insight?

Visit our health & beauty page for more insight on the channel